Localized Therapeutics is a biotech startup in the newly emerging field of photogenetics. Gene therapy is an emerging field of medicine that holds promise for the treatment of many diseases, especially ones whose root cause can be traced back to faulty gene operation, caused by genetic mutation, aging and lifestyle. In contrast to chemical drugs and biologics, gene therapy can deliver functioning genes into cells using artificial viruses, thereby treating symptoms. Combining light control with gene therapy, the firm's proprietary process utilizes a DNA sequence that is laser-activated (Laser Switch TM) temporarily to activate therapeutic transgenes, producing localized biological drugs naturally in the body. The Localized Therapeutics process makes gene therapy safe by adding on/off control of gene expression, and by localizing it to the individual organ or area of treatment. With treatments not given systemically and dosage is controlled by the Laser Switch via safe, natural, low level laser light, side effects are virtually non-existent. Localized Therapeutics is initially targeting Rheumatoid Arthritis since current medications only slow the progression of the disease and many many of those medications are losing patent protection.
